Similar articles for PMID: 31939447

Year	Number of Results
2013	1
2014	1
2017	4
2018	18
2019	30
2020	30
2021	17
2022	12
2023	5
2024	0

1

Salvage therapy of reactive capillary hemangiomas: Apatinib alleviates the unique adverse events induced by camrelizumab in non-small cell lung cancer.

Li W, Wei Z, Yang X, Huang G, Han X, Ni Y, Wang J, Meng M, Zou Z, Wen Q, Ye X. Li W, et al. J Cancer Res Ther. 2019;15(7):1624-1628. doi: 10.4103/jcrt.JCRT_997_19. J Cancer Res Ther. 2019. PMID: 31939447 Free article.

2

Study protocol: A single-arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first-line immunotherapy.

Xing P, Wang M, Zhao J, Zhong W, Chi Y, Xu Z, Li J. Xing P, et al. Thorac Cancer. 2021 Oct;12(20):2825-2828. doi: 10.1111/1759-7714.14113. Epub 2021 Aug 18. Thorac Cancer. 2021. PMID: 34409776 Free PMC article. Clinical Trial.

3

Camrelizumab combined with microwave ablation improves the objective response rate in advanced non-small cell lung cancer.

Wei Z, Yang X, Ye X, Huang G, Li W, Han X, Wang J, Meng M, Ni Y, Zou Z, Wen Q. Wei Z, et al. J Cancer Res Ther. 2019;15(7):1629-1634. doi: 10.4103/jcrt.JCRT_990_19. J Cancer Res Ther. 2019. PMID: 31939448 Free article.

4

Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy.

Zhou C, Wang Y, Zhao J, Chen G, Liu Z, Gu K, Huang M, He J, Chen J, Ma Z, Feng J, Shi J, Yu X, Cheng Y, Yao Y, Chen Y, Guo R, Lin X, Wang Z, Gao G, Wang Q, Li W, Yang X, Wu L, Zhang J, Ren S. Zhou C, et al. Clin Cancer Res. 2021 Mar 1;27(5):1296-1304. doi: 10.1158/1078-0432.CCR-20-3136. Epub 2020 Dec 15. Clin Cancer Res. 2021. PMID: 33323401 Clinical Trial.

5

Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature.

Liu L, Liu Y, Gong L, Zhang M, Wu W. Liu L, et al. Cancer Biol Ther. 2020 Nov 1;21(11):983-989. doi: 10.1080/15384047.2020.1829265. Epub 2020 Oct 23. Cancer Biol Ther. 2020. PMID: 33092443 Free PMC article. Review.

6

Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial.

Mei K, Qin S, Chen Z, Liu Y, Wang L, Zou J. Mei K, et al. J Immunother Cancer. 2021 Mar;9(3):e002191. doi: 10.1136/jitc-2020-002191. J Immunother Cancer. 2021. PMID: 33741732 Free PMC article. Clinical Trial.

7

Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial.

Cheng H, Zong L, Kong Y, Wang X, Gu Y, Cang W, Zhao J, Wan X, Yang J, Xiang Y. Cheng H, et al. Lancet Oncol. 2021 Nov;22(11):1609-1617. doi: 10.1016/S1470-2045(21)00460-5. Epub 2021 Oct 5. Lancet Oncol. 2021. PMID: 34624252 Clinical Trial.

8

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.

Zhang B, Qi L, Wang X, Xu J, Liu Y, Mu L, Wang X, Bai L, Huang J. Zhang B, et al. Cancer Commun (Lond). 2020 Dec;40(12):711-720. doi: 10.1002/cac2.12119. Epub 2020 Dec 12. Cancer Commun (Lond). 2020. PMID: 33314747 Free PMC article. Clinical Trial.

9

Hypophysitis: A rare but noteworthy immune-related adverse event secondary to camrelizumab therapy.

Han X, Meng M, Zhang T, Wang J, Huang G, Ni Y, Li W, Dai J, Yang X, Ye X. Han X, et al. J Cancer Res Ther. 2022 Sep;18(5):1440-1443. doi: 10.4103/jcrt.jcrt_831_21. J Cancer Res Ther. 2022. PMID: 36204895 Free article.

10

Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.

Xie L, Xu J, Sun X, Guo W, Gu J, Liu K, Zheng B, Ren T, Huang Y, Tang X, Yan T, Yang R, Sun K, Shen D, Li Y. Xie L, et al. J Immunother Cancer. 2020 May;8(1):e000798. doi: 10.1136/jitc-2020-000798. J Immunother Cancer. 2020. PMID: 32376724 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year